Grape King Bio Ltd.(TW:1707)
NT$78.70-0.60 (-0.76%)
TW:1707
Grape King Bio Ltd. financials statements
NT$78.70
At close:-0.60 (-0.76%)
Grape King Bio Ltd. (1707) Financial Statements
Grape King Bio Ltd. Financial Overview
Grape King Bio Ltd.'s market cap is currently NT$11.75B. The company's EPS TTM is NT$7.75; its P/E ratio is 10.96; and it has a dividend yield of 7.62%. Grape King Bio Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 10.25B | NT$ 11.16B | NT$ 10.64B | NT$ 10.39B | NT$ 9.80B |
| Gross Profit | NT$ 7.70B | NT$ 8.66B | NT$ 8.54B | NT$ 8.48B | NT$ 7.86B |
| Operating Income | NT$ 2.14B | NT$ 2.50B | NT$ 2.50B | NT$ 2.69B | NT$ 2.42B |
| EBITDA | NT$ 2.69B | NT$ 3.17B | NT$ 3.12B | NT$ 3.13B | NT$ 2.83B |
| Net Income | NT$ 1.22B | NT$ 1.45B | NT$ 1.45B | NT$ 2.17B | NT$ 1.95B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 4.28B | NT$ 4.43B | NT$ 4.97B | NT$ 4.79B | NT$ 3.90B |
| Total Assets | NT$ 15.74B | NT$ 15.32B | NT$ 15.51B | NT$ 15.05B | NT$ 14.06B |
| Total Debt | NT$ 215.03M | NT$ 160.91M | NT$ 192.92M | NT$ 157.75M | NT$ 271.76M |
| Net Debt | NT$ -3.95B | NT$ -4.18B | NT$ -4.63B | NT$ -4.52B | NT$ -3.36B |
| Total Liabilities | NT$ 3.67B | NT$ 3.53B | NT$ 3.88B | NT$ 3.91B | NT$ 3.63B |
| Stockholders' Equity | NT$ 10.34B | NT$ 10.06B | NT$ 9.98B | NT$ 9.57B | NT$ 8.99B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 1.73B | NT$ 1.23B | NT$ 1.92B | NT$ 2.49B | NT$ 2.26B |
| Operating Cash Flow | NT$ 2.18B | NT$ 1.88B | NT$ 2.52B | NT$ 2.99B | NT$ 2.54B |
| Investing Cash Flow | NT$ -580.08M | NT$ -662.11M | NT$ -654.73M | NT$ -330.31M | NT$ -462.34M |
| Financing Cash Flow | NT$ -1.77B | NT$ -1.72B | NT$ -1.71B | NT$ -1.63B | NT$ -1.37B |
Currency in TWD
